Related Episodes for Considerations for glutamine supplementation as it relates to gut health and cancer

“Dr. Patrick also describes a proposed anti-metastatic mechanism: faster blood flow during vigorous exercise increases shear forces on circulating tumor cells, the cells that have left a primary tumor and entered the bloodstream.”

“In this excerpt from Dr. Rhonda Patrick’s A4M LongevityFest 2023 keynote, she reviews a randomized trial in sedentary middle-aged adults. Two years of progressive, supervised aerobic training increased VO2 max and reduced left-ventricular stiffness.”

“In this clip, Drs. Levine and Patrick discuss genetic and environmental factors that can accelerate or slow epigenetic aging. Dr. Levine also discusses the aging clock she created and how it can be used, along with other biomarkers, to determine an individual's rate of aging.”

“Dr. Patrick explains some of the early evidence that suggests the value prolonged fasting (48+ hours) may have from the standpoint of tissue rejuvenation and healthspan maintenance, as well as relevance for other more specific conditions.”

“Gaining FDA approval of psilocybin under these conditions is problematic, however, due to the negative connotations associated with the compound's use and the potential for harm when used in vulnerable populations.”

“A large meta-analysis found that protein supplementation improved resistance-training gains in muscle size and strength, with little additional lean-mass benefit above an estimated total intake of about 1.6 grams per kilogram per day for most participants.”

“Dr. Patrick also cautions that glutamine can serve as fuel for rapidly dividing cells; people with cancer, a history of polyps, or active gastrointestinal disease should not treat supplementation as routine and should discuss it with a clinician.”

“Long-lived people eventually develop age-related diseases – just later in life, a phenomenon referred to as “compression of morbidity.” The onset of these diseases is influenced by a variety of factors, including genetics, environment, and lifestyle.”

“Earlier long-term research in older male physicians found no cognitive benefit, and the main COSMOS trial did not significantly reduce invasive cancer, cardiovascular events, or mortality over a median of 3.6 years.”

“In a secondary analysis of 72 men, the combined concentration of six PFAS declined by about 8 percent within the oat beta-glucan group over four weeks, while the study did not distinguish the magnitude of change from the control group.”